BlackRock’s Medline Inc MDLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04B Buy
26,393,587
+9,469,927
+56% +$382M 0.02% 750
2026
Q1
$753M Buy
16,923,660
+5,410,710
+47% +$239M 0.01% 839
2025
Q4
$484M Buy
+11,512,950
New +$486M 0.01% 1125

Other funds holding MDLN

BlackRock's MDLN Position: Q2 2026 in Review

BlackRock increased its Medline Inc (MDLN) stake by 56% in Q2 2026, buying an estimated $382M and bringing the position to 26,393,587 shares worth $1.04B. The position accounts for 0.02% of the portfolio, ranked #750.

BlackRock first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. 406 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • BlackRock held 26,393,587 shares of Medline Inc worth $1.04B as of Q2 2026.
  • BlackRock bought 9,469,927 Medline Inc shares in Q2 2026, an estimated $382M.
  • Medline Inc made up 0.02% of BlackRock's portfolio in Q2 2026, its #750 holding.
  • BlackRock first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • 406 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.